These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28294176)

  • 21. Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy.
    Wang HL; Mo DC; Zhong JH; Ma L; Wu FX; Xiang BD; Li LQ
    Medicine (Baltimore); 2019 Feb; 98(8):e14498. PubMed ID: 30813151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis.
    Hu Z; Wang W; Li Z; Ye S; Zheng SS
    Liver Transpl; 2012 Nov; 18(11):1316-23. PubMed ID: 22847898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC.
    Hu Z; Zhang Q; Zhou J; Li Z; Xiang J; Zhou L; Wu J; Zhang M; Zheng S
    BMJ Open; 2015 Sep; 5(9):e008429. PubMed ID: 26353871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis.
    Vennarecci G; Ettorre GM; Antonini M; Santoro R; Maritti M; Tacconi G; Spoletini D; Tessitore L; Perracchio L; Visco G; Puoti C; Santoro E
    Transplant Proc; 2007; 39(6):1857-60. PubMed ID: 17692633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis.
    Li HY; Wei YG; Yan LN; Li B
    World J Gastroenterol; 2012 May; 18(19):2415-22. PubMed ID: 22654435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.
    Ali MA; Li WF; Wang JH; Lin CC; Chen YJ; Lin TL; Lin TS; Lu SN; Wang CC; Chen CL
    HPB (Oxford); 2016 Oct; 18(10):851-860. PubMed ID: 27567971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study.
    Wang P; Pu Y; Li H; Shi B; Zheng S; Zhong L
    Springerplus; 2016; 5(1):1809. PubMed ID: 27818858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
    Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
    Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
    Halazun KJ; Najjar M; Abdelmessih RM; Samstein B; Griesemer AD; Guarrera JV; Kato T; Verna EC; Emond JC; Brown RS
    Ann Surg; 2017 Mar; 265(3):557-564. PubMed ID: 27611615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm and Benefits of Salvage Transplantation for Hepatocellular Carcinoma: An Updated Meta-analysis.
    Xiong Q; Geng TT; He L; Gao H
    Transplant Proc; 2016 Dec; 48(10):3336-3347. PubMed ID: 27931579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel nomogram for prognosis stratification in salvage liver transplantation: a national-wide study with propensity score matching analysis in China.
    Wang K; Gao F; Dong S; Ding J; Dong L; Shao C; Wang Z; Qiu X; Wei X; Wang Z; Yang J; Xia Q; Zheng S; Xu X
    Hepatobiliary Surg Nutr; 2023 Dec; 12(6):854-867. PubMed ID: 38115922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.